Condition: Staphylococcus Aureus Bacteraemia · Staphylococcal Bacteraemia · Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) · Sponsor: Region Skane
The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.
This description comes directly from the study's public registry record.
Malin Hagstrand Aldman, PhD · +46768766308 · malin.hagstrand-aldman@skane.se
Lisa I Påhlman, PhD, MD · Lisa.pahlman@med.lu.se
Always discuss trial participation with your own doctor first.
| Skånes universitetssjukhus, Region Skåne | Lund, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06726395